Emergent BioSolutions Inc. Share Price & Technical Analysis
EBS · $8.45 (+0.96%)
Healthcare / Drug Manufacturers - Specialty & Generic
$8.45
+0.96%
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intrave…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
-7% return in May, 71% avg return in past 3 year May month.
-43% return in 2026, 78% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -9% | -28% | 2% | -1% | -7% | – | – | – | – | – | – | – | -43% |
| 25 | 17% | -29% | -36% | 10% | 17% | 2% | -5% | 46% | 6% | 42% | -10% | 12% | 71% |
| 24 | -26% | 88% | -22% | -24% | 200% | 21% | 87% | -35% | 4% | 10% | 11% | -5% | 309% |
| 23 | 9% | -5% | -16% | -15% | -2% | -15% | -7% | -36% | -29% | -38% | 0% | 9% | -146% |
| 22 | 7% | -12% | 1% | -22% | 3% | -5% | 12% | -31% | -11% | -3% | -42% | -5% | -107% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the treatment of infection caused by Orthoebolavirus zairense; Raxibacumab injection, a monoclonal antibody therapeutic for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis; TEMBEXA, an oral antiviral for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; and CNJ-016, a polyclonal antibody therapeutic to address complications from smallpox vaccination. It also provides NARCAN and KLOXXADO nasal sprays for the emergency treatment of known or suspected opioid overdose. In addition, the company offers contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, analytical development, and suite reservation services. Emergent BioSolutions Inc. was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$438.57M
P/E ratio
—
52W high
$14.06
52W low
$5.62
Volume
8,68,367
Beta
2.33
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Emergent BioSolutions Inc. share price today?
- Emergent BioSolutions Inc. (EBS) last traded around $8.45 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does EBS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for EBS. Download the app for real-time alerts.
- How can I analyze Emergent BioSolutions Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.